Bone marrow suppressing agents
US4882142A · kind A · utility
34Cited by
2References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 19, 1988 |
| Grant date | Nov 21, 1989 |
| Priority date | — |
| Expiry date | Dec 19, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2121/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention concerns a method for suppressing bone marrow which comprises administering to a mammal at least one bone marrow suppressing complex of a radionuclide selected from the group consisting of Samarium-153, Gadolinium-159, and Holmium-166 and 1,4,7,10-tetraazacyclododecanetetramethylenephosphonic acid a physiologically acceptable salt thereof. Suitable compositions for use in this method are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.